AbbVie’s Epcoritamab shows progression-free survival gain in relapsed/refractory DLBCL trial
Improvements were also seen in complete response rates, duration of response, and time to next treatment
Improvements were also seen in complete response rates, duration of response, and time to next treatment
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Over 8.8?million Indians aged 60 and above currently live with dementia,
India in the Changing Landscape of Life-Sciences Research & Development
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
Subscribe To Our Newsletter & Stay Updated